Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the schedule hereto:
Schedule
Product: Onkotrone
Active Ingredient(s): Mitoxantrone hydrochloride 2.328mg/mL equivalent to 2mg/mL mitoxantrone
Dosage Form: Concentrate for injection
NZ Sponsor: New Zealand Medical & Scientific Ltd
Manufacturer(s): Asta Medica AG, Halle-Kunsebeck, Germany
Dated this 16th day of February 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).